Oric Pharmaceuticals Inc (ORIC)
Healthcare
Biotechnology
11.10 $
-4.9%
vs. previous close
Closing price · As of: 31. Jul 2026
Oric Pharmaceuticals Inc (ORIC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -113 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| -21 | -21 | -24 | -45 | -60 | -75 | -86 | -113 | -113 | |
| 0.9 | 0.9 | 1.0 | 1.0 | 0.9 | 1.0 | 1.0 | 1.1 | 1.2 | |
| 0.0 | 0.5 | 1.1 | 5.3 | 13 | 14 | 15 | 20 | 25 | |
| 0.3 | 0.5 | 1.1 | 25 | 13 | 15 | – | – | – | |
| 0.1 | -0.7 | 1.2 | 2.0 | 4.1 | -0.4 | 4.9 | 2.0 | -5.5 | |
| 0.5 | 0.5 | 0.8 | 0.7 | 0.9 | 2.1 | 0.8 | 1.2 | 0.7 | |
| -0.3 | -0.5 | -0.8 | -216 | 158 | -109 | -43 | 22 | -148 | |
| – | 38 | 71 | 272 | 51 | 0.5 | – | – | – | |
| 0.3 | 38 | 71 | 251 | 49 | 25 | 86 | 127 | 248 | |
| -21 | 17 | 47 | -11 | 148 | -159 | -43 | 36 | -14 | |
| -21 | -21 | -24 | -46 | -60 | -77 | -87 | -114 | -114 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.